Aylin Onan Yilmaz - Infectious Diseases

Author Information

Aylin Onan Yilmaz is a researcher affiliated with the Department of Infectious Diseases at the University of Gothenburg in Gothenburg, Sweden. Her work focuses primarily on infectious diseases, with a particular emphasis on the impacts and biomarkers of viral infections such as COVID-19 and HIV.

Research Contributions

Aylin Onan Yilmaz has made significant contributions to the field of infectious diseases, particularly in understanding the cardiovascular and immune system implications of viral infections. Her research includes studying cardiac dysfunction in critically ill COVID-19 patients, examining biomarkers related to ischemic heart injury, and investigating immune responses in individuals on pre-exposure prophylaxis (PrEP) for HIV. She has extensively explored the effects of antiretroviral treatments and the prevalence of drug resistance in HIV-1 infections. Her work also includes longitudinal studies on immune responses to SARS-CoV-2 in healthcare workers.

Aliases

Aylin Onan Yilmaz is also known by various aliases including A Yilmaz, Aylin. Yilmaz, and Aylin Yilmaz.

Publication and Citation Metrics

Metric	Value
Total Citations	1803
h-index	23
Total Papers	68

Publications:

Cardiac dysfunction and mortality in critically ill patients with COVID‐19: A Swedish multicentre observational study

DOI: 10.1111/aas.14039

Year: 2022

No difference in biomarkers of ischemic heart injury and heart failure in patients with COVID-19 who received treatment with chloroquine phosphate and those who did not

DOI: 10.1371/journal.pone.0256035

Year: 2021

Cardiac Dysfunction in Critically Ill patients with COVID-19 – A Multicentre Observational Study

DOI: 10.21203/rs.3.rs-138541/v1

Year: 2021

Increased immune activation and signs of neuronal injury in HIV-negative people on pre-exposure prophylaxis (PrEP).

DOI: 10.1097/QAD.0000000000002980

Year: 2021

Proteomic blood profiling in mild, severe and critical COVID-19 patients

DOI: 10.1038/s41598-021-85877-0

Year: 2021

Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection

DOI: 10.1186/s12883-021-02527-8

Year: 2021

Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4+ T-Cell Responses

DOI: 10.3389/fimmu.2021.750448

Year: 2021

Failure to restore CD4+ cell count associated with infection-related and noninfection-related cancer

DOI: 10.1097/QAD.0000000000003117

Year: 2021

Correction: Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders

DOI: 10.1371/journal.pone.0258401

Year: 2021

High-throughput sequencing reveals a high prevalence of pretreatment HIV-1 drug resistance in Sweden.

DOI: 10.1097/QAD.0000000000002740

Year: 2021

What is the Prognosis for Individuals with HSV?

Why are ACTs Important in Malaria Treatment?

What are Some Examples of Structural Proteins in Infectious Diseases?

How Often Should You Get a Health Check-Up?

How is Plasmodium falciparum diagnosed?

What are the applications of RT-PCR in Infectious Diseases?

How Do Fungal Pathogens Affect Us?

Who is eligible for Dengvaxia?

What Causes Vaccine Hesitancy?

How can Plasmodium falciparum malaria be prevented?

Partnered Content Networks

Relevant Topics